OrthoPediatrics stock forecast
OrthoPediatrics (2X7) Stock Forecast & Price Target
2X7 Analyst Ratings
2X7 Stock 12 Month Forecast
Average Price Target
€27.34▼(-5.06% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ryan Zimmerman | BTIG | €26.31→€27.21 | buy | -5.51%Downside | Reiterated | 10/28/26 | ||
| Caitlin Roberts | Canaccord Genuity | €25.40→€27.21 | buy | -5.51%Downside | Reiterated | 10/28/26 | ||
| Matthew O'Brien | Piper Sandler | €22.68→€27.21 | buy | -5.51%Downside | Reiterated | 10/28/26 | ||
| Rick Wise | Stifel Nicolaus | €21.77→€24.49 | buy | -14.95%Downside | Reiterated | 10/28/26 | ||
| Mathew Blackman | TD Cowen | €20.86→€25.40 | buy | -11.80%Downside | Reiterated | 10/28/26 | ||
| Ben Haynor | Lake Street | €30.84→€34.47 | buy | 19.69%Upside | Reiterated | 10/28/26 | ||
| Ravi Misra | Truist Financial | €19.96→€25.40 | hold | -11.80%Downside | Reiterated | 10/28/26 | ||
| Michael Matson | Needham | €31.75 | buy | 10.24%Upside | Reiterated | 08/05/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ryan ZimmermanBTIG | BuyReiterated€26.31→€27.21 | 10/28/26 | -5.51%Downside | ||
| Caitlin RobertsCanaccord Genuity | BuyReiterated€25.40→€27.21 | 10/28/26 | -5.51%Downside | ||
| Matthew O'BrienPiper Sandler | BuyReiterated€22.68→€27.21 | 10/28/26 | -5.51%Downside | ||
| Rick WiseStifel Nicolaus | BuyReiterated€21.77→€24.49 | 10/28/26 | -14.95%Downside | ||
| Mathew BlackmanTD Cowen | BuyReiterated€20.86→€25.40 | 10/28/26 | -11.80%Downside | ||
| Ben HaynorLake Street | BuyReiterated€30.84→€34.47 | 10/28/26 | 19.69%Upside | ||
| Ravi MisraTruist Financial | HoldReiterated€19.96→€25.40 | 10/28/26 | -11.80%Downside | ||
| Michael MatsonNeedham | BuyReiterated€31.75 | 08/05/26 | 10.24%Upside |
Best Analysts Covering OrthoPediatrics
Copying Matthew O'Brien's trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +2.86% per trade.
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of -0.41% per trade.
Copying Ryan Zimmerman's trades and holding each position for 2 Years would result in 48.15% of your transactions generating a profit, with an average return of +9.32% per trade.
2X7 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 2 | 0 |
| Buy | 5 | 10 | 8 | 14 | 7 |
| Hold | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 14 | 12 | 18 | 8 |
In the current month, 2X7 has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 2X7 average Analyst price target in the past 3 months is 27.34.
2X7 Financial Forecast
2X7 Earnings Forecast
Next quarter’s earnings estimate for 2X7 is -EUR 0.19 with a range of -EUR 0.23 to -EUR 0.15. The previous quarter’s EPS was -EUR 0.22. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
2X7 Sales Forecast
Next quarter’s sales forecast for 2X7 is EUR 61.83M with a range of EUR 61.33M to EUR 62.19M. The previous quarter’s sales results were EUR 65.06M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

